SOX2 and non-small cell lung carcinoma: Moreover, FGFR1 increases Gli2 and SOX2 expressions to promote stemness, proliferation, epithelial-to-mesenchymal transition (EMT), and metastasis of non-small cell lung cancer (NSCLC) cells 16, 17.